Abstracts tagged "diagnostic criteria and pediatrics"

Abstract Number: 1494 • 2017 ACR/ARHP Annual Meeting
Validation of New Criteria in “The Guidance for Diagnosis of Sjögren’s Syndrome in Pediatric Patients”
Minako Tomiita¹, Ichiro Kobayashi², Yuzaburo Inoue³, Nami Okamoto⁴, Naomi Iwata⁵, Yukiko Nonaka⁶, Ryoki Hara⁷, Hiroaki Umebayashi⁸, Yasuhiko Itoh⁹ and Masaaki Mori¹⁰, ¹Department of Allergy and Rheumatology, Chiba Children's Hospital, Chiba, Japan, ²Department of Allergy and Rheumatology, Chiba Children’s Hospital, Sapporo, Japan, ³Department of Pediatrics, Chiba University Graduate School of Medicine, Chiba, Japan, ⁴Pediatrics, Graduate School of Medicine, Osaka Medical College, Takatsuki, Japan, ⁵Department of Immunology and Infectious Diseases, Aichi Children’s Health and Medical Center, Obu, Japan, ⁶Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan, Kagoshima, Japan, ⁷Department of Pediatrics, Yokohama City University, Graduate School of Medicine, Yokohama, Japan, ⁸Department of Rheumatics, Miyagi Children’s Hospital, Sendai, Japan, ⁹Department of Pediatrics, Nippon Medical School, Tokyo, Japan, ¹⁰Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
Background/Purpose: Sjögren’s syndrome (SS) has been thought rare during pediatric age. Because patients in this age group lack gsicca symptomsh, the diagnosis of SS is…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].